MSCRF Manufacturing Assistance Program supports Maryland companies and organizations in building or acquiring GMP manufacturing platforms to enable timely, cost-effective production of human stem cell therapies.
Funder: Maryland Technology Development Corporation (TEDCO)
Due Dates: January 20, 2027, at 5:00 p.m. EST (Application) | Week of April 4, 2027 (Peer review and presentations) | May 2027 (Award announcements)
Funding Amounts: Up to $1,000,000 for up to 24 months; minimum 1:1 match of non-state money required
Summary: Supports Maryland companies and organizations building or acquiring manufacturing platforms for GMP production of human stem cell therapy products.
Key Information: All funded work and the manufacturing facility must be in Maryland.
The Maryland Stem Cell Research Fund (MSCRF), administered by TEDCO, provides initial resources to advance good manufacturing practice (GMP) production of cell therapy products in Maryland. Manufacturing Assistance grants support building or acquiring modular manufacturing facilities, prefabricated clean rooms, closed systems, and similar manufacturing platforms. Projects involve human stem cells, their derivatives—including extracellular vesicles and secretome—or technologies enabling or supporting human stem cells.
The program addresses manufacturing challenges as cell-based treatments advance toward the clinic. It aims to accelerate timely, cost-effective production that meets identified market needs while supporting and retaining Maryland’s advanced manufacturing workforce. It also encourages collaboration across academic schools, departments, and institutions and between public and private sectors.